Nitrofurantoin Pharmsol (Nitrofurantoin)

Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins, and carbohydrate‑metabolizing enzymes. This multi‑targeted attack disrupts essential bacterial functions, resulting in bactericidal activity that is concentrated in the urine.

The specific dose and duration are determined by the prescribing clinician based on the patient’s condition, renal function, and local treatment guidelines. Healthcare professionals should follow the recommended dosing instructions on the prescription label.

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and limited human data. It is generally considered safe in early pregnancy but should be avoided in late pregnancy. Breastfeeding mothers should consult their physician before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Compared with trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin has a narrow spectrum focused on common urinary pathogens and achieves high urinary concentrations with limited systemic exposure. It is often preferred for uncomplicated cystitis due to lower resistance rates, but it is not suitable for pyelonephritis or patients with poor renal function.

Store the tablets at temperatures below 25 °C in their original container, protecting them from moisture and direct sunlight. Do not expose the product to excessive heat or humidity, and keep it out of reach of children.

Nitrofurantoin Pharmsol is taken orally, usually with food or a full glass of water to improve absorption and reduce gastrointestinal irritation. The tablets should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include pulmonary toxicity (interstitial lung disease or acute respiratory distress), severe hepatic injury, and hypersensitivity reactions such as rash, swelling, or anaphylaxis. Patients should seek immediate medical attention if they experience breathing difficulties, persistent fever, or signs of liver dysfunction.

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to nitrofurantoin, G6PD deficiency, and in late pregnancy. Caution is also advised for elderly patients and those with a history of pulmonary or hepatic disease.